Perbedaan Organon Pharma Indonesia Tbk. dan Samudera Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Samudera Indonesia Tbk. diperdagangkan di Rp392 (kapitalisasi pasar 6,29 T, volume 24 jam 52,26 jt). Perbedaan utamanya: Samudera Indonesia Tbk. jauh lebih besar — sekitar 60,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SMDR | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 6,29 T |
Volume | — | 52,26 jt |
Lot | — | 522,58 rb |
Perputaran | — | 19,94 M |
Harga Rata-rata | — | 381,6 |
Nilai Transaksi | — | 19,94 M |
Harga Ekuilibrium Indikatif | — | 392 |
Volume Ekuilibrium Indikatif | — | 25,18 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Samudera Indonesia Tbk (the Company) was established on November 13, 1964 under the framework of the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970, based on notarial deed No. 33 of Soeleman Ardjasasmita, S.H. PT. Samudera Indonesia Tbk offers a full range of transportation services from feeder, tanker, offshore and land transportation for containers and heavy equipment to container depots and warehousing as well as freight forwarding services. In 1997, SSL, a subsidiary, listed on the Singapore Exchange Securities Trading Ltd.
Selengkapnya di halaman SMDR →